HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection

Clicks: 485
ID: 114868
2007
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 46 articles by views in The International journal on drug policy

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Early acquisition of hepatitis C virus (HCV) infection appears to affect a substantial proportion of injection drug users (IDUs)--between 20 percent and 90 percent. Analysing the range of HCV prevalence estimates in new injectors may help identify factors that can be modified to reduce HCV transmiss …
Reference Key
h2007thehcv Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hagan H;Des Jarlais DC;Stern R;Lelutiu-Weinberger C;Scheinmann R;Strauss S;Flom PL;;
Journal The International journal on drug policy
Year 2007
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/17854721
Keywords
meta-analysis National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support adult female male N.I.H. Extramural age factors risk factors time factors substance abuse hepatitis c / epidemiology* hepatitis c / transmission risk assessment prevalence research design holly hagan don c des jarlais pmid:17854721 doi:10.1016/j.drugpo.2007.01.016 peter l flom epidemiologic methods harm reduction health education hepatitis c / prevention & control national health programs intravenous / epidemiology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.